Physician
Garcia-Albarran, Carmen
Garcia-Albarran, Carmen was paid $338K by Medicaid between Jan 2018 and Nov 2024, across 93 billing codes. Its largest line is 90460, Immunization administration through 18 years of age via any route, first or only component — 19% of everything it billed.
33Billing provider infoGARCIA-ALBARRAN, CARMEN
NEW YORK, NY 10033
NEW YORK, NY 10033
33aNPI1174610760assigned 10/06/2006
33bProvider typePediatrics Physician
28Total paid$338K
24GClaims68,863
24DCodes billed93
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#497 of 1,983
Median peer was paid$17K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,130 | $42K | |
| 2019 | 8,872 | $48K | |
| 2020 | 14,094 | $51K | |
| 2021 | 19,809 | $109K | |
| 2022 | 10,514 | $29K | |
| 2023 | 936 | $4K | |
| 2024incomplete | 9,508 | $56K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 19% | 3,193 | 3,118 | $63K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 6,550 | 5,652 | $55K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 14% | 1,514 | 1,466 | $46K |
| 92587 | 13% | 2,719 | 2,706 | $45K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 4.5% | 978 | 962 | $15K |
| 99401 | 3.8% | 4,247 | 3,943 | $13K | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | 3.3% | 3,131 | 2,858 | $11K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.0% | 2,401 | 2,182 | $10K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.5% | 275 | 270 | $8K |
| 86328 | 2.2% | 552 | 547 | $8K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.4% | 301 | 287 | $5K |
| 87631 | 1.2% | 395 | 383 | $4K |
81 more codes
| D1206 | Topical application of fluoride varnish | 1.0% | 146 | $4K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 444 | $3K |
| 36410 | <1% | 2,287 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 419 | $3K |
| 87110 | <1% | 175 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 130 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 203 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 302 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 210 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 218 | $2K |
| 99441 | <1% | 325 | $2K | |
| 83655 | <1% | 247 | $2K | |
| 86769 | <1% | 446 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 817 | $2K |
| 99177 | <1% | 2,519 | $2K | |
| H0049 | Alcohol and/or drug screening | <1% | 783 | $2K |
| 0072A | <1% | 46 | $2K | |
| 94642 | <1% | 173 | $2K | |
| 0071A | <1% | 44 | $2K | |
| 90661 | <1% | 42 | $1K | |
| 97802 | <1% | 986 | $1K | |
| 94200 | <1% | 460 | $1K | |
| 90686 | <1% | 1,112 | $1K | |
| 90660 | <1% | 101 | $1K | |
| 99188 | <1% | 107 | $949.48 | |
| 90656 | <1% | 111 | $920.04 | |
| A4614 | Peak expiratory flow rate meter, hand held | <1% | 462 | $906.98 |
| 99173 | <1% | 807 | $707.94 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 82 | $704.02 |
| 81002 | <1% | 2,349 | $682.75 | |
| 90461 | <1% | 192 | $554.86 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 151 | $471.81 |
| 0004A | <1% | 13 | $422.22 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 129 | $249.07 |
| 94664 | <1% | 117 | $180.55 | |
| 92557 | <1% | 38 | $167.76 | |
| 90688 | <1% | 175 | $158.75 | |
| 81000 | <1% | 553 | $154.44 | |
| 97803 | <1% | 29 | $150.36 | |
| H0001 | Alcohol and/or drug assessment | <1% | 746 | $144.57 |
| 96127 | <1% | 834 | $138.84 | |
| 93000 | <1% | 15 | $130.08 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 308 | $128.60 |
| 80061 | Lipid panel | <1% | 123 | $108.72 |
| 90674 | <1% | 97 | $100.00 | |
| 99000 | <1% | 2,820 | $85.00 | |
| 86580 | <1% | 14 | $79.39 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 508 | $78.00 |
| 36406 | <1% | 48 | $74.44 | |
| 90672 | <1% | 30 | $26.88 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | <1% | 1,815 | $20.00 |
| G0271 | Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes | <1% | 40 | $18.60 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 2,297 | $15.00 |
| 81001 | <1% | 19 | $3.81 | |
| 91307 | <1% | 99 | $0.26 | |
| 91300 | <1% | 31 | $0.10 | |
| 90633 | 0% | 54 | $0.00 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 714 | $0.00 |
| 3725F | 0% | 644 | $0.00 | |
| 99072 | 0% | 958 | $0.00 | |
| G9820 | Documentation of a chlamydia screening test with proper follow-up | 0% | 654 | $0.00 |
| 3016F | 0% | 477 | $0.00 | |
| 99080 | 0% | 1,999 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 196 | $0.00 |
| 90670 | 0% | 12 | $0.00 | |
| 90648 | 0% | 12 | $0.00 | |
| 90715 | 0% | 12 | $0.00 | |
| 3078F | 0% | 73 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 916 | $0.00 |
| 1036F | 0% | 645 | $0.00 | |
| 3008F | 0% | 4,342 | $0.00 | |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 768 | $0.00 |
| 3048F | 0% | 471 | $0.00 | |
| 90620 | 0% | 461 | $0.00 | |
| 94760 | 0% | 145 | $0.00 | |
| 1000F | 0% | 645 | $0.00 | |
| S8110 | Peak expiratory flow rate (physician services) | 0% | 431 | $0.00 |
| 90651 | 0% | 59 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 35 | $0.00 |
| 90619 | 0% | 17 | $0.00 | |
| 3074F | 0% | 73 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.